jRCT2080221233未知1 期
Phase I Clinical Study of E7389 in Patients With Solid Tumors
试验速览
- 阶段
- 1 期
- 入组人数
- 24
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open-Label study
入排标准
- 年龄范围
- 20age old over 至 75age old under（—）
- 性别
- All
入选标准
- •Patients with histologically or cytologically confirmed solid tumors.
- •Patients who have progressed on or following standard therapy and with no other treatment options.
- •Patients having a performance status (PS) of Eastern Cooperative Oncology Group (ECOG) 0 or 1.
排除标准
- •Patients with systemic infection with a fever (38°C).
- •Patients with a large amount of pleural effusion, ascites and pericardial fluid requiring drainage.
- •Patients with brain metastasis with clinical symptoms.
结局指标
主要结局
-
Dose limiting toxicity (DLT) and maximum tolerated dose (MTD)
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
A phase 2a study of S-637880 in patients with neuropathic low back painjRCT2031200418Shionogi & Co., Ltd.160
已完成
1 期
Phase 1 study of E7386 in subjects with advanced solid tumors including colorectal cancerjRCT2080224589Eisai Co., Ltd.70
未知
3 期
A Phase 3 study of S-474474 in patients with essential hypertensioHypertensionJPRN-jRCT2080221505SHIONOGI & CO., LTD.
未知
3 期
A Phase 3 study of S-474474 in patients with essential hypertensionHypertensionjRCT2080221505SHIONOGI & CO., LTD.
未知
2 期
Phase IIa Study of S-555739 in Patients with Perennial Allergic RhinitisPerennial allergic rhinitisJPRN-jRCT2080220844SHIONOGI & CO., LTD.